Latest Content

Today is World Stroke Day. Understanding what lies ahead in the road to stroke recovery can help patients and their families prepare for the challenges they will face.

Cingulate's CTx-1301 shows promising phase 3 results for ADHD, offering effective once-daily dosing and potential FDA approval by 2026.

Experts discuss the dangers of chatbots in mental health, highlighting their inaccuracies, biases, and potential harm to vulnerable patients.

Halloween can trigger trauma for some, while others embrace it as a playful way to confront fears and express creativity.

American psychiatry reexamines its roots in psychopathology, challenging DSM's validity and advocating for a return to understanding mental illness.

Ukrainian physicians enhance pain management and trauma care skills at Yale, fostering international collaboration to improve healthcare amid ongoing conflict.

The "No Kings" rallies highlight a growing demand for democratic leadership amid political tensions, reflecting societal concerns over mental health and governance.

New research reveals how Candida albicans in the gut microbiome influences alcohol consumption and aversion, offering insights for treating alcohol use disorder.

This week's research on semaglutide, tips on study trial analysis, and issues in older adult psychiatry.

As Halloween approaches, the rise in decorations and costumes reflects our cultural response to anxiety and societal challenges.

Laguna Diagnostics revolutionizes psychiatric interventions with patented blood tests that accurately diagnose schizophrenia and bipolar disorder.

What is the power of solitude vs loneliness? Can embracing solitude enhance creativity and mental well-being?

Tardive dyskinesia significantly impacts older adults in long-term care, necessitating timely recognition and effective treatment strategies for improved quality of life.